Overview

Study of Botulinum Toxin in Patients With Primary Hyperhidrosis

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
OBJECTIVES: I. Determine the optimal dose of botulinum toxin necessary to decrease sweating in patients with primary hyperhidrosis.
Phase:
N/A
Details
Lead Sponsor:
Icahn School of Medicine at Mount Sinai
Treatments:
abobotulinumtoxinA
Botulinum Toxins
Botulinum Toxins, Type A
incobotulinumtoxinA
onabotulinumtoxinA